HYPOTHALAMIC-PITUITARY-ADRENAL AXIS PERTURBATIONS IN PATIENTS WITH FIBROMYALGIA

被引:408
作者
CROFFORD, LJ
PILLEMER, SR
KALOGERAS, KT
CASH, JM
MICHELSON, D
KLING, MA
STERNBERG, EM
GOLD, PW
CHROUSOS, GP
WILDER, RL
机构
[1] NIAMSD, BETHESDA, MD 20892 USA
[2] NIMH, BETHESDA, MD 20892 USA
[3] NICHHD, BETHESDA, MD 20892 USA
来源
ARTHRITIS AND RHEUMATISM | 1994年 / 37卷 / 11期
关键词
D O I
10.1002/art.1780371105
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To examine basal and stimulated hypothalamic-pituitary-adrenal (HPA) axis and related hormone levels, including adrenocorticotropin (ACTH), cortisol, arginine vasopressin (AVP), and neuropeptide Y (NPY), in patients with fibromyalgia (FM). Methods. Basal and ovine corticotropin-releasing hormone (oCRH)-stimulated HPA axis function were assessed in 12 patients with FM and in age- and sex-matched normal subjects. Basal plasma AVP levels and AVP release after postural change were assessed, and plasma NPY levels were measured in the same samples. Results. Patients with FM had low 24-hour urinary free cortisol, but normal peak and elevated trough plasma cortisol levels, compared with normal subjects. The net integrated ACTH response to oCRH in FM was not significantly different from that in normal subjects, but tended toward an exaggerated response. There was a significant decrease in net integrated cortisol response to oCRH in FM patients, indicating adrenal hyporesponsiveness. AVP levels were not significantly different between FM patients and control subjects, but variability was greater among the FM patients. Plasma NPY levels were significantly lower in FM patients than in normal subjects. Conclusion. These data support the view that HPA axis function is perturbed in patients with FM. Further study is required to ascertain the cause of HPA axis perturbations and their relationship to symptoms in patients with FM.
引用
收藏
页码:1583 / 1592
页数:10
相关论文
共 51 条
[1]   PSYCHOLOGICAL-FACTORS ASSOCIATED WITH PRIMARY FIBROMYALGIA SYNDROME [J].
AHLES, TA ;
YUNUS, MB ;
RILEY, SD ;
BRADLEY, JM ;
MASI, AT .
ARTHRITIS AND RHEUMATISM, 1984, 27 (10) :1101-1106
[2]   NEUROPEPTIDE-Y DISTRIBUTION IN THE RAT-BRAIN [J].
ALLEN, YS ;
ADRIAN, TE ;
ALLEN, JM ;
TATEMOTO, K ;
CROW, TJ ;
BLOOM, SR ;
POLAK, JM .
SCIENCE, 1983, 221 (4613) :877-879
[3]   LOW-LEVELS OF SOMATOMEDIN C IN PATIENTS WITH THE FIBROMYALGIA SYNDROME - A POSSIBLE LINK BETWEEN SLEEP AND MUSCLE PAIN [J].
BENNETT, RM ;
CLARK, SR ;
CAMPBELL, SM ;
BURCKHARDT, CS .
ARTHRITIS AND RHEUMATISM, 1992, 35 (10) :1113-1116
[4]   INTRAVENTRICULAR CORTICOTROPIN-RELEASING FACTOR ENHANCES BEHAVIORAL-EFFECTS OF NOVELTY [J].
BRITTON, DR ;
KOOB, GF ;
RIVIER, J ;
VALE, W .
LIFE SCIENCES, 1982, 31 (04) :363-367
[5]   CORTICOTROPIN-RELEASING FACTOR - ACTIONS ON THE SYMPATHETIC NERVOUS-SYSTEM AND METABOLISM [J].
BROWN, MR ;
FISHER, LA ;
SPIESS, J ;
RIVIER, C ;
RIVIER, J ;
VALE, W .
ENDOCRINOLOGY, 1982, 111 (03) :928-931
[6]   CLINICAL CHARACTERISTICS OF FIBROSITIS .1. A BLINDED, CONTROLLED-STUDY OF SYMPTOMS AND TENDER POINTS [J].
CAMPBELL, SM ;
CLARK, S ;
TINDALL, EA ;
FOREHAND, ME ;
BENNETT, RM .
ARTHRITIS AND RHEUMATISM, 1983, 26 (07) :817-824
[7]   DOUBLE-BLIND-STUDY OF 5-HYDROXYTRYPTOPHAN VERSUS PLACEBO IN THE TREATMENT OF PRIMARY FIBROMYALGIA SYNDROME [J].
CARUSO, I ;
PUTTINI, PS ;
CAZZOLA, M ;
AZZOLINI, V .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1990, 18 (03) :201-209
[8]   THE CONCEPTS OF STRESS AND STRESS SYSTEM DISORDERS - OVERVIEW OF PHYSICAL AND BEHAVIORAL HOMEOSTASIS [J].
CHROUSOS, GP ;
GOLD, PW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (09) :1244-1252
[9]  
DAILEY PA, 1990, J RHEUMATOL, V17, P1380
[10]   REPEATED STRESS-INDUCED ACTIVATION OF CORTICOTROPIN-RELEASING FACTOR NEURONS ENHANCES VASOPRESSIN STORES AND COLOCALIZATION WITH CORTICOTROPIN-RELEASING FACTOR IN THE MEDIAN-EMINENCE OF RATS [J].
DE GOEIJ, DCE ;
KVETNANSKY, R ;
WHITNALL, MH ;
JEZOVA, D ;
BERKENBOSCH, F ;
TILDERS, FJH .
NEUROENDOCRINOLOGY, 1991, 53 (02) :150-159